It was well known that Wnt/MAPK/PI3K-AKT signaling pathway promoted the progression of EMT in lung cancer, prostate cancer, nasopharyngeal carcinoma, cervical cancer, breast cancer, and so on50–54. This evidence concerns the gene AKT1 and breast carcinoma.